Online Only Articles

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia

Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden
Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden
Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden
Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden
Department of Biosciences and Nutrition and Center for Innovative (CIMED), Karolinska Institutet, Sweden
Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm, Sweden
Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden
Department of Biosciences and Nutrition and Center for Innovative (CIMED), Karolinska Institutet, Sweden;Molecular Neurology Research Program, University of Helsinki and Folkhälsan Institute of Genetics, Helsinki, Finland
Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden
Vol. 100 No. 6 (2015): June, 2015 https://doi.org/10.3324/haematol.2014.118034